Compare ALEMBIC with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs ALEMBIC PHARMA - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC ALEMBIC PHARMA ALEMBIC/
ALEMBIC PHARMA
 
P/E (TTM) x 74.5 16.6 449.4% View Chart
P/BV x 6.4 6.6 97.5% View Chart
Dividend Yield % 0.2 0.6 27.4%  

Financials

 ALEMBIC   ALEMBIC PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-18
ALEMBIC PHARMA
Mar-19
ALEMBIC/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs72664 10.8%   
Low Rs34412 8.2%   
Sales per share (Unadj.) Rs4.7208.7 2.3%  
Earnings per share (Unadj.) Rs6.131.0 19.7%  
Cash flow per share (Unadj.) Rs6.237.1 16.8%  
Dividends per share (Unadj.) Rs0.205.50 3.6%  
Dividend yield (eoy) %0.41.0 37.0%  
Book value per share (Unadj.) Rs40.7144.2 28.2%  
Shares outstanding (eoy) m267.03188.52 141.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.32.6 436.8%   
Avg P/E ratio x8.717.4 50.0%  
P/CF ratio (eoy) x8.514.5 58.5%  
Price / Book Value ratio x1.33.7 34.9%  
Dividend payout %3.317.7 18.5%   
Avg Mkt Cap Rs m14,139101,461 13.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2077,467 2.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,25539,347 3.2%  
Other income Rs m37094 394.7%   
Total revenues Rs m1,62539,441 4.1%   
Gross profit Rs m1118,736 1.3%  
Depreciation Rs m381,152 3.3%   
Interest Rs m2184 0.9%   
Profit before tax Rs m4427,493 5.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m1,212-93 -1,306.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m241,568 1.5%   
Profit after tax Rs m1,6305,844 27.9%  
Gross profit margin %8.922.2 39.9%  
Effective tax rate %5.420.9 25.9%   
Net profit margin %129.814.9 874.3%  
BALANCE SHEET DATA
Current assets Rs m1,86719,577 9.5%   
Current liabilities Rs m59114,896 4.0%   
Net working cap to sales %101.611.9 854.4%  
Current ratio x3.21.3 240.3%  
Inventory Days Days9490 105.0%  
Debtors Days Days7445 162.2%  
Net fixed assets Rs m1,79127,097 6.6%   
Share capital Rs m534377 141.7%   
"Free" reserves Rs m10,32426,811 38.5%   
Net worth Rs m10,85827,188 39.9%   
Long term debt Rs m414,993 0.8%   
Total assets Rs m11,59147,778 24.3%  
Interest coverage x260.941.7 625.6%   
Debt to equity ratio x00.2 2.1%  
Sales to assets ratio x0.10.8 13.1%   
Return on assets %14.112.6 111.6%  
Return on equity %15.021.5 69.8%  
Return on capital %15.223.6 64.4%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1919,453 0.1%   
Fx outflow Rs m2646,065 4.4%   
Net fx Rs m-24413,388 -1.8%   
CASH FLOW
From Operations Rs m2368,120 2.9%  
From Investments Rs m-224-7,556 3.0%  
From Financial Activity Rs m-27590 -4.5%  
Net Cashflow Rs m-151,153 -1.3%  

Share Holding

Indian Promoters % 64.0 74.1 86.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 2.9 6.9%  
FIIs % 9.7 9.1 106.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 13.9 187.8%  
Shareholders   54,701 49,328 110.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   BIOCON   CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  WOCKHARDT  

Compare ALEMBIC With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


May 12, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS